The impact of early target attainment of vancomycin in critically ill patients with confirmed Gram-positive infection: A retrospective cohort study

The impact of early target attainment of vancomycin in critically ill patients with confirmed Gram-positive infection: A retrospective cohort study

Abstract Background Vancomycin is a commonly used antibiotic in critically ill patients for various indications. Critical illness imposes pharmacokinetic-pharmacodynamics challenges, which makes optimizing vancomycin in this population cumbersome. Data are scarce on the clinical impact of time to th...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Khalid Al Sulaiman, Abdulrahman Alshaya, Ohoud Aljuhani, Amjad Alsaeed, Nadiyah Alshehri, Ramesh Vishwakarma, Hamdan Alzahrani, Sara Althewaibi, Nawaf Alghamdi, Khalid Alhelal, Aisha Alharbi, Shmeylan Al Harbi
Formato: article
Lenguaje:EN
Publicado: BMC 2021
Materias:
Vancomycin
Trough level
Mortality
Infection
Critical care
Intensive care unit
Infectious and parasitic diseases
RC109-216
Acceso en línea:https://doaj.org/article/c302358cd79b435f8eb8155df1f5a136
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Internet

https://doaj.org/article/c302358cd79b435f8eb8155df1f5a136

Ejemplares similares